Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,365
  • Shares Outstanding, K 464
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,500 K
  • 60-Month Beta 2.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SCNI with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.23 +33.63%
on 06/10/24
6.97 -57.25%
on 06/17/24
-0.77 (-20.53%)
since 05/31/24
3-Month
2.23 +33.63%
on 06/10/24
6.97 -57.25%
on 06/17/24
-1.85 (-38.29%)
since 04/02/24
52-Week
2.23 +33.63%
on 06/10/24
18.70 -84.07%
on 07/12/23
-11.12 (-78.87%)
since 06/30/23

Most Recent Stories

More News
Scinai Immunotherapeutics (NASDAQ: SCNI) Releases Q1 2024 Financial Reports

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

AMD : 164.31 (+4.20%)
SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Releases FY 2023 Financial Results

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) to Present at Europe Dermatology Drug Development Summit

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI), Scinai Bioservices Enter MSA with Ayana Pharma

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products, through its contract development and manufacturing...

SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Showcasing Services at Upcoming BIO-Europe Spring 2024

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing CDMO services through...

SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

NVS : 106.44 (-0.09%)
SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Research Collaborator Receives Louis-Jeantet Prize

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products, is congratulating its colead scientific...

KHC : 32.00 (+0.44%)
SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Agreement for Exercise of Outstanding Warrants

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products and...

SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports on Preclinical Results from Psoriatic Human Skin Trial

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products, has...

SCNI : 2.98 (+1.36%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Announced Peer-Reviewed Journal Publishes Data Supporting NanoAbs

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products, is...

SCNI : 2.98 (+1.36%)

Business Summary

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 3.34
2nd Resistance Point 3.22
1st Resistance Point 3.10
Last Price 2.98
1st Support Level 2.86
2nd Support Level 2.73
3rd Support Level 2.61

See More

52-Week High 18.70
Fibonacci 61.8% 12.41
Fibonacci 50% 10.47
Fibonacci 38.2% 8.52
Last Price 2.98
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar